News

Back

TheraVet launches a prospective multicentric clinical trial in canine osteosarcoma

November 17th 2020

BioPark

TheraVet S.A., the specialist of the osteo-articular diseases of small companion animals, announces the launch of a prospective multicentric clinical trial in canine osteosarcoma with BIOCERA-VET, TheraVet’s injectable synthetic self-hardening calcium-phosphate cement. Discover the press release here.